Aetion, Inc.
9
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
11.1%
1 terminated/withdrawn out of 9 trials
87.5%
+1.0% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Saphnelo Use in Females of Child-bearing Potential
Role: collaborator
Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran
Role: collaborator
CARE Initiative: Real-world Emulation of the PALOMA-2 Trial
Role: lead
CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]
Role: lead
Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments
Role: lead
CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4]
Role: lead
A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ During Pregnancy
Role: collaborator
Emulation of the KEYNOTE-189 Trial Using Electronic Health Records
Role: lead
Dexamethasone and COVID-19 Inpatient Mortality
Role: lead
All 9 trials loaded